SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-006722
Filing Date
2022-02-24
Accepted
2022-02-24 16:21:55
Documents
100
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K psnl-10k_20211231.htm   iXBRL 10-K 4378081
2 EX-10.16 psnl-ex1016_256.htm EX-10.16 63913
3 EX-10.18 psnl-ex1018_257.htm EX-10.18 21755
4 EX-10.19 psnl-ex1019_363.htm EX-10.19 72159
5 EX-10.20 psnl-ex1020_362.htm EX-10.20 82481
6 EX-10.21 psnl-ex1021_361.htm EX-10.21 82486
7 EX-21.1 psnl-ex211_10.htm EX-21.1 7695
8 EX-23.1 psnl-ex231_222.htm EX-23.1 2663
9 EX-31.1 psnl-ex311_7.htm EX-31.1 21224
10 EX-31.2 psnl-ex312_12.htm EX-31.2 21422
11 EX-32.1 psnl-ex321_13.htm EX-32.1 9364
12 EX-32.2 psnl-ex322_6.htm EX-32.2 9371
13 EX-99.1 psnl-ex991_258.htm EX-99.1 4357
14 GRAPHIC gzdtlr3cvigl000002.jpg GRAPHIC 88449
15 GRAPHIC gzdtlr3cvigl000001.jpg GRAPHIC 33908
16 GRAPHIC gzdtlr3cvigl000003.jpg GRAPHIC 153651
17 GRAPHIC grqszzzzm120000001.jpg GRAPHIC 887
  Complete submission text file 0001564590-22-006722.txt   16285927

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA psnl-20211231.xsd EX-101.SCH 77273
19 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE psnl-20211231_cal.xml EX-101.CAL 80557
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE psnl-20211231_def.xml EX-101.DEF 307175
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE psnl-20211231_lab.xml EX-101.LAB 632060
22 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE psnl-20211231_pre.xml EX-101.PRE 512235
94 EXTRACTED XBRL INSTANCE DOCUMENT psnl-10k_20211231_htm.xml XML 3214291
Mailing Address 1330 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1330 O'BRIEN DRIVE MENLO PARK CA 94025 650-752-1300
Personalis, Inc. (Filer) CIK: 0001527753 (see all company filings)

IRS No.: 275411038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38943 | Film No.: 22671326
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences